San Diego, CA, United States of America

Vasco A Oliveira

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Burnham Institute for Medical Research, The Burnham Institute. Active years: 2007-2009.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vasco A Oliveira: Innovator in Polypeptide Research

Introduction

Vasco A Oliveira is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and their applications. With a total of two patents to his name, Oliveira's work has implications for diagnostics and therapeutic methods.

Latest Patents

Oliveira's latest patents focus on caspase recruitment domain (CARD)-containing polypeptides. These inventions provide insights into the structure and function of CARD, NB-ARC, ANGIO-R, LRR, and SAM domains. The patents also encompass encoding nucleic acid molecules and specific antibodies, along with related screening, diagnostic, and therapeutic methods.

Career Highlights

Throughout his career, Vasco A Oliveira has worked with prestigious institutions such as the Burnham Institute and the Burnham Institute for Medical Research. His research has contributed to advancements in medical science and biotechnology.

Collaborations

Some of Oliveira's notable coworkers include John C Reed and Frederick F Pio. Their collaborative efforts have furthered research in the field and enhanced the impact of their findings.

Conclusion

Vasco A Oliveira's innovative work in polypeptide research and his contributions to biotechnology highlight his role as a significant inventor in the scientific community. His patents and collaborations continue to influence advancements in medical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…